Copyright
©2010 Baishideng.
World J Gastroenterol. Jun 21, 2010; 16(23): 2913-2917
Published online Jun 21, 2010. doi: 10.3748/wjg.v16.i23.2913
Published online Jun 21, 2010. doi: 10.3748/wjg.v16.i23.2913
Figure 1 Flow chart summarizing the cessation and restart of antithrombotic drugs in endoscopic submucosal dissection (ESD)[6].
Warfarin is discontinued before ESD and heparin is initiated if needed. PT-INR is checked 3 to 4 d later; if PT-INR ≤ 1.5, ESD can be performed. After surgery warfarin is immediately restarted, and heparin is co-administered in patients at high risk for disease. Antiplatelet drugs are discontinued before ESD as well (aspirin, 3 d before ESD; ticlopidine, 5 d before ESD); they are immediately restarted after the procedure. PT-INR: Prothrombin time-international normalized ratio.
Figure 2 The margin and center areas of the ulcer floor.
The margin includes the outer 5 mm edge of the ulcer, and the remaining area is defined as the center.
- Citation: Tsuji Y, Ohata K, Ito T, Chiba H, Ohya T, Gunji T, Matsuhashi N. Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions. World J Gastroenterol 2010; 16(23): 2913-2917
- URL: https://www.wjgnet.com/1007-9327/full/v16/i23/2913.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i23.2913